Osaic Holdings’s Vertex Pharmaceuticals VRTX Stock Holding History

Osaic Holdings’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$10.6K	Hold	1	–	–	﹤0.01%	6253
2025 Q4	$11.6K	Hold	1	–	–	﹤0.01%	6246
2025 Q3	$7.6K	Hold	1	–	–	﹤0.01%	6527
2025 Q2	$12.7K	Hold	1	–	–	﹤0.01%	6013
2025 Q1	$16.4K	Hold	1	–	–	﹤0.01%	5489
2024 Q4	$5.6K	Buy	+1	New	+$464	﹤0.01%	6129
2024 Q2	–	Sell	-1	Closed	-$9.97K	–	7630
2024 Q1	$9.97K	Hold	1	–	–	﹤0.01%	5741
2023 Q4	$9.4K	Hold	1	–	–	﹤0.01%	5861
2023 Q3	$5.42K	Hold	1	–	–	﹤0.01%	6238
2023 Q2	$6.59K	Hold	1	–	–	﹤0.01%	6186
2023 Q1	$3.87K	Buy	+1	New	+$300	﹤0.01%	6461
2022 Q4	–	Sell	-1	Closed	-$6K	–	7445
2022 Q3	$6K	Buy	+1	New	+$288	﹤0.01%	6308

Other funds holding VRTX

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Osaic Holdings's VRTX Position: Q1 2026 in Review

Osaic Holdings increased its Vertex Pharmaceuticals (VRTX) stake by 0.5% in Q1 2026, buying an estimated $103K and bringing the position to 43,972 shares worth $19.6M. The position accounts for 0.03% of the portfolio, ranked #584.

Osaic Holdings first reported a position in VRTX in Q1 2020 and has held it in 25 quarters since. The position peaked at $40.4M in Q3 2023. 1,687 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.

Osaic Holdings held 43,972 shares of Vertex Pharmaceuticals worth $19.6M as of Q1 2026.
Osaic Holdings bought 220 Vertex Pharmaceuticals shares in Q1 2026, an estimated $103K.
Vertex Pharmaceuticals made up 0.03% of Osaic Holdings's portfolio in Q1 2026, its #584 holding.
Osaic Holdings first reported a position in Vertex Pharmaceuticals in Q1 2020 and has held it in 25 quarters since.
Osaic Holdings's Vertex Pharmaceuticals position peaked at $40.4M in Q3 2023.
1,687 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.

Based on Osaic Holdings's 13F filing for Q1 2026, filed 15 May 2026.